Redwoods Acquisition Corporation (RWODU)

UNIMAGINABLE DUMPING

Anyone know what the conversion will be for wena merger? 1 to 175?

Back to $7.40s

Wake me up when this gets volume so I can join

From a spread of .65 to a penny fun to watch

Are wash trades legal? LOL

What happened

Where that volume go after 6 halts yesterday LOL

Hold $7- 7.42 let’s see if it’s stays up.. NEW YORK, March 4, 2024 /PRNewswire/ -- ANEW MEDICAL, INC. ("ANEW" or "the Company") (OTCPK: LEAS) a US-based biotechnology company ("ANEW") focused on developing cell and gene- based treatments to affect aging and age-related diseases, announced that is has been granted and issued a patent in China, number CN 117126829 A for the use of ANEW's Klotho protein and Klotho gene delivery and expression systems in the treatment of cognition, memory and neurodegenerative diseases. This intellectual property was licensed by ANEW from UNIVERSITAT AUTÒNOMA DE BARCELONA (UAB) and INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS (ICREA) in Barcelona, Spain on an exclusive worldwide basis and ANEW paid for all patent costs associated with obtaining –the patent.

Most likely another scam...

Now May 1st. Total dud.

What a turd

April 1st came and went. Maybe May 1st

By the end of May probably.

Scary

Premarket today back to 8. What a POS.

When is the ticker change?

Didn’t do much after PM.

So, essentially all of the IPO stock (and the cash in the treasury) is being redeemed, leaving the coffers essentially bare. Seems the common shareholders knew better than the $60M valuation crap on an OTC company trading for a fraction of that with nothing going on. The O/S when it settles will be 3.5M-sh, 9.5M-ish when they give the stock to the ANEW folks (dilution), and you'll have a company that hasn't done jack for a couple years with no cash to do anything with, even after the business combination, with 9.5M shares in the O/S at an unknown price. Right out of the gate, they're going to have to do an offering to raise cash.
NASDAQ investors pay attention to business performance. When they see the balance sheet of this combined company with nothing going on and nothing to do it with, they're not going to be lining up to get in on an offering and are going to laugh at the $60M "valuation" RWOD assigned to it.

RWOD closed yesterday at 7.99 and now premarket is up at 12.78. 1.2 million shares! Crazy.

And just like that

Crazy whoever is buying up here

The recent spacs sure haven’t done well after ticker change

It is happening. Let’s just wait for April 1st

they have to pay $60000 per month to extent this merger, I don't see them dropping it.so it will happen.

$RWOD $LEAS DEF 14A
https://www.sec.gov/Archives/edgar/data/1907223/000121390023082438/def14a1023_redwoods.htm

$RWOD $LEAS 10/17 S4
https://www.sec.gov/ix?doc=/Archives/edgar/data/0001907223/000101376223004459/fs42023a1_redwood.htm

$RWOD filed 14A
https://www.sec.gov/Archives/edgar/data/1907223/000101376223004108/ea186816-pre14a_redwoods.htm
$LEAS

Slowly getting some volume......LEAS
Nice Bid building

Need to get $LEAS on a good run!!!

$RWOD 9/25 updated 8K https://www.sec.gov/ix?doc=/Archives/edgar/data/0001907223/000121390023079137/ea185721-8k_redwoods.htm

$RWOD $LEAS Filed 10-Q last night https://www.sec.gov/ix?doc=/Archives/edgar/data/1907223/000121390023069521/f10q0623_redwoodsacq.htm

Picking up some volume today 220k

$RWOD 10Q filed this morning
https://www.sec.gov/Archives/edgar/data/1907223/000121390023067293/ea183427-nt10q_redwoods.htm

Rituximab is top-selling oncology drug with sales reaching $8.58 billion.

https://www.frontiersin.org/journals/oncology/articles/10.3389/fonc.2018.00163/full

true that.

Nice.....RWOD deserves a board for their shareholders to discuss the company........

Z

For what?

Go on anewmeds.com

I own some leas

#1 Short play $RWOD

yup nice trading range too.

SPACs usually loose all their value after the merger... Might be a good Short play here

did you buy leas as well,this board wasn't here yesterday, brand new right.

Welcome sauna

Second

WELCOME TO RWOD BOARD